Human Papillomavirus Therapy
Research on human papillomavirus therapy detailed by scientists at University of Turin
Published in Proteomics Weekly, January 1st, 2007
Research findings, "Effect of high-risk human papillomavirus oncoproteins on p53R2 gene expression after DNA damage," are discussed in a new report. "The p53R2 protein is a p53-inducible small subunit of ribonucleotide reductase. It plays a crucial role in p53-dependent cellular response to DNA damage and oxidative stress by providing deoxyribonucleotides (dNTPs) to the DNA repair machinery and by scavenging reactive oxygen species (ROS)," scientists in Turin, Italy report.
"To investigate the effects of high-risk human papillomavirus (HPV) oncoproteins on p53R2 expression after DNA damage, we analyzed the p53R2 protein levels in human cells ectopically expressing the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
Source: Proteomics Weekly (2007-01-01)
More Articles from Proteomics Weekly
- Alzheimer Disease
Protein fingerprint in spinal fluid could spot Alzheimer disease - Angiogenesis
Research on angiogenesis reported by scientists at Taipei Medical University, Department of Neurology - Colon Cancer Therapy
Data on colon cancer therapy discussed by researchers at Tzu Chi University, Institute of Pharmacology and Toxicology - Fusion Proteins
Research conducted at Michigan State University has updated our knowledge about fusion proteins - Fusion Proteins
Study results from Yonsei University, Department of Anatomy provide new insights into fusion proteins - Hepatitis C Virus Vaccines
Study results from Second Military Medical University, Department of Microbiology provide new insights into hepatitis c virus vaccines - More from this issue of Proteomics Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
